Valuation: bioMérieux

Market Cap 8.36B 9.53B 7.74B 7.12B 13.47B 912B 13.73B 92.25B 36.18B 448B 35.78B 35B 1,547B P/E 2026 *
17x
P/E 2027 * 15.2x
Enterprise Value 7.92B 9.03B 7.34B 6.75B 12.77B 864B 13.02B 87.44B 34.29B 424B 33.91B 33.17B 1,466B EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.74x
Free-Float
33.22%
Yield 2026 *
1.51%
Yield 2027 * 1.6%
1 day+1.50%
1 week+1.87%
Current month+3.13%
1 month+4.58%
3 months-21.28%
6 months-34.40%
Current year-35.77%
1 week 68.25
Extreme 68.25
71.95
1 month 65.6
Extreme 65.6
71.95
Current year 65.6
Extreme 65.6
116.1
1 year 65.6
Extreme 65.6
128.3
3 years 65.6
Extreme 65.6
128.3
5 years 65.6
Extreme 65.6
133.2
10 years 39.5
Extreme 39.5
144.8
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2023
Director of Finance/CFO 50 01/03/2018
Chief Tech/Sci/R&D Officer - 01/08/2022
Director TitleAgeSince
Chairman 76 01/01/2014
Chairman 52 15/12/2017
Director/Board Member 65 01/01/2005
Date Insider Type Main position Quantity % Market Cap.
05-06Buy

Chairman

779,245 0.6584%
05-06Buy

Chairman

779,245 0.6584%
05-04Buy

Chairman

404,367 0.3416%
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%+1.87%-40.61%-24.56% 9.41B
-1.03%-6.17%+215.22%+307.83% 21.22B
-0.24%+2.50%+29.62%+24.84% 6.88B
-2.25%+4.42%+226.33%-27.51% 5.42B
+1.47%+7.93%-19.88%-29.81% 5.05B
+0.41%-4.21%-35.65% - 4.8B
0.00%-0.97%-23.35%-26.37% 4.17B
-5.85%-12.54%+51.09%+59.58% 3.64B
+1.36%+0.22%-17.57%-44.14% 2.59B
-3.87%-11.49%-36.10%+188.34% 1.61B
Average -0.85%+0.11%+34.91%+47.58% 6.48B
Weighted average by Cap. -0.56%-0.67%+82.25%+107.81%

Financials

2026 *2027 *
Net sales 4.11B 4.68B 3.8B 3.5B 6.62B 448B 6.75B 45.32B 17.77B 220B 17.58B 17.19B 760B 4.37B 4.99B 4.05B 3.73B 7.05B 477B 7.19B 48.27B 18.93B 234B 18.72B 18.31B 809B
Net income 495M 565M 459M 422M 799M 54.06B 814M 5.47B 2.14B 26.55B 2.12B 2.07B 91.69B 554M 632M 513M 472M 893M 60.47B 911M 6.12B 2.4B 29.7B 2.37B 2.32B 103B
Net Debt -436M -497M -404M -371M -703M -47.56B -716M -4.81B -1.89B -23.36B -1.87B -1.83B -80.66B -757M -863M -701M -645M -1.22B -82.62B -1.24B -8.36B -3.28B -40.57B -3.24B -3.17B -140B
Logo bioMérieux
bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.3%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.7%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East /Africa (32.3%), North America (45.4%), Asia/Pacific (15.6%), and Latin America (6.7%).
Employees
14,894
Date Price Change Volume
13/07/26 €70.85 +1.50% 140,725
10/07/26 €69.80 -2.58% 293,066
09/07/26 €71.65 +3.62% 230,702
08/07/26 €69.15 -1.98% 185,747
07/07/26 €70.55 +1.44% 149,479
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
70.85EUR
Average target price
82.19EUR
Spread / Average Target
+16.00%

Quarterly revenue - Rate of surprise